Literature DB >> 21691730

Psychiatric symptoms screening in the early stages of Parkinson's disease.

Paulo Bugalho1, Joaquim Alves da Silva, Inês Cargaleiro, Madalena Serra, Bernardo Neto.   

Abstract

Psychiatric complaints are common in Parkinson's disease (PD), and have a significant influence in disease outcome and quality of life. Little attention has been paid to psychiatric symptoms at early stage disease. We aimed to screen a population of early stage PD patients for psychiatric symptoms and to study the relation with motor and cognitive function. Thirty-six early stage PD patients underwent motor [Hoehn and Yahr (HY), Unified Parkinson's Disease Rating Scale] and cognitive [Frontal Assessment Battery, Mini-Mental State Examination (MMSE)] assessment as well as general psychiatric [Symptom Check-List 90 (SCL-90-R)] and psychosis [Brief Psychiatric Rating Scale (BPRS)] screening. Relation between psychiatric domains scores was studied with principal component analysis. Relation between psychiatric, disease related, cognitive and motor function was assessed with bivariate correlation (Pearson). SCL-90-R scores were higher for somatization (significant scores in 66.7% of patients), depression (36.1%), anxiety (27%) and obsessive-compulsive symptoms (OCS) (52.8%). Scores were highly correlated, except for psychosis and phobia. Depression and anxiety were negatively correlated to MMSE score and dopaminergic doses, respectively. BPRS scores were higher for somatic concern, depression, anxiety and hallucinations. There was segregation between depression, anxiety, hallucinations, other positive psychotic symptoms and negative psychotic symptoms. Depression was related to MMSE score. We found a high prevalence of psychiatric complaints in PD patients, mostly related to depression, anxiety, somatization and OCS. Hallucinations were also frequent, but not associated to cognitive function or dopaminergic doses, suggesting a different physiopathological background.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21691730     DOI: 10.1007/s00415-011-6140-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  32 in total

1.  Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease.

Authors:  Gregory M Pontone; James R Williams; Karen E Anderson; Gary Chase; Susanne A Goldstein; Stephen Grill; Elaina S Hirsch; Susan Lehmann; John T Little; Russell L Margolis; Peter V Rabins; Howard D Weiss; Laura Marsh
Journal:  Mov Disord       Date:  2009-07-15       Impact factor: 10.338

2.  Cohort study on somatoform disorders in Parkinson disease and dementia with Lewy bodies.

Authors:  Marco Onofrj; Laura Bonanni; Lamberto Manzoli; Astrid Thomas
Journal:  Neurology       Date:  2010-05-18       Impact factor: 9.910

3.  Old-onset Parkinson's disease compared with young-onset disease: clinical differences and similarities.

Authors:  A Friedman
Journal:  Acta Neurol Scand       Date:  1994-04       Impact factor: 3.209

4.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

5.  The FAB: a Frontal Assessment Battery at bedside.

Authors:  B Dubois; A Slachevsky; I Litvan; B Pillon
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

6.  Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study.

Authors:  D Aarsland; J P Larsen; J L Cummins; K Laake
Journal:  Arch Neurol       Date:  1999-05

Review 7.  Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force.

Authors:  Bruno Dubois; David Burn; Christopher Goetz; Dag Aarsland; Richard G Brown; Gerald A Broe; Dennis Dickson; Charles Duyckaerts; Jefferey Cummings; Serge Gauthier; Amos Korczyn; Andrew Lees; Richard Levy; Irene Litvan; Yoshikuni Mizuno; Ian G McKeith; C Warren Olanow; Werner Poewe; Cristina Sampaio; Eduardo Tolosa; Murat Emre
Journal:  Mov Disord       Date:  2007-12       Impact factor: 10.338

8.  Scales to assess psychosis in Parkinson's disease: Critique and recommendations.

Authors:  Hubert H Fernandez; Dag Aarsland; Gilles Fénelon; Joseph H Friedman; Laura Marsh; Alexander I Tröster; Werner Poewe; Olivier Rascol; Cristina Sampaio; Glenn T Stebbins; Christopher G Goetz
Journal:  Mov Disord       Date:  2008-03-15       Impact factor: 10.338

9.  A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson's disease patients without dementia.

Authors:  A McKinlay; R C Grace; J C Dalrymple-Alford; T Anderson; J Fink; D Roger
Journal:  Parkinsonism Relat Disord       Date:  2007-07-12       Impact factor: 4.891

10.  Evidence for atypical depression in Parkinson's disease.

Authors:  R B Schiffer; R Kurlan; A Rubin; S Boer
Journal:  Am J Psychiatry       Date:  1988-08       Impact factor: 18.112

View more
  7 in total

1.  The factor structure of the Brief Symptom Inventory-18 (BSI-18) in Parkinson disease patients.

Authors:  Danielle S Abraham; Ann L Gruber-Baldini; Donna Harrington; Lisa M Shulman
Journal:  J Psychosom Res       Date:  2017-03-06       Impact factor: 3.006

2.  Path analysis of biomarkers for cognitive decline in early Parkinson's disease.

Authors:  Dmitri K Gramotnev; Galina Gramotnev; Alexandra Gramotnev; Mathew J Summers
Journal:  PLoS One       Date:  2022-05-13       Impact factor: 3.752

Review 3.  Neurodegeneration in Parkinson's disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins.

Authors:  George Anderson; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-10-02       Impact factor: 5.590

Review 4.  Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's disease.

Authors:  Edward C Lauterbach
Journal:  Am J Neurodegener Dis       Date:  2016-03-01

5.  Drug-induced Pressure Ulcers in a Middle-aged Patient with Early-stage Parkinson's Disease.

Authors:  Yuichi Hayashi; Hideaki Shibata; Takuya Kudo; Shohei Nishida; Rie Ishikawa; Chie Moriya; Akio Suzuki; Akio Kimura; Takashi Inuzuka
Journal:  Intern Med       Date:  2017-12-27       Impact factor: 1.271

6.  Non-Motor symptoms in Portuguese Parkinson's Disease patients: correlation and impact on Quality of Life and Activities of Daily Living.

Authors:  Paulo Bugalho; Tânia Lampreia; Rita Miguel; Marcelo D Mendonça; André Caetano; Raquel Barbosa
Journal:  Sci Rep       Date:  2016-08-30       Impact factor: 4.379

7.  Somatic symptoms disorders in Parkinson's disease are related to default mode and salience network dysfunction.

Authors:  Raffaella Franciotti; Stefano Delli Pizzi; Mirella Russo; Claudia Carrarini; Danilo Carrozzino; Bernardo Perfetti; Marco Onofrj; Laura Bonanni
Journal:  Neuroimage Clin       Date:  2019-07-15       Impact factor: 4.881

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.